PDGFRA CAR mRNA-LNP
Cat. No.: TDLD-0825-LD38
PDGFRA CAR mRNA-LNP
PDGFRA CAR mRNA-LNP is a state-of-the-art messenger RNA (mRNA) lipid nanoparticle (LNP) system, specifically engineered for efficient in vitro and in vivo protein expression. This LNP encapsulates mRNA encoding the Chimeric Antigen Receptor (CAR) targeting Platelet-Derived Growth Factor Receptor Alpha (PDGFRA), serving as an excellent tool for investigating CAR-T cell therapy against PDGFRA-expressing tumors and studying receptor-specific immune modulation. Engineered with a proprietary lipid formulation for optimal mRNA encapsulation and delivery, it ensures high translation efficiency. Our LNP ensures uniform particle size, high encapsulation efficiency, stability, and effective delivery. Applications of PDGFRA CAR mRNA-LNP include monitoring CAR expression on transduced T cells and evaluating CAR-T cell functionality against PDGFRA-positive targets. Please note that this product is intended for research purposes only.
| Payload Type | CAR mRNA |
| Payload | PDGFRA CAR mRNA |
| Modification | Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other |
| Module Type | Unconjugation |
| LNP Type | CAR mRNA-LNP |
| Lipid Formulation | SM102 |
| Dye | Unlabeled |
| Application | Gene Therapy; CAR-T |
| Format | Liquid |
| Concentration | 0.1 mg/mL; 0.2 mg/mL; Other (Please Specify) |
| Size | 65-120 nm |
| PDI | < 0.2 |
| Zeta | ± 20.0 mV |
| Encapsulate Efficiency | >90% |
| Shipping | Dry Ice |
| Storage | Store at -80°C |
Click the button below to contact us or submit your feedback about this product.
